Search research articles
Contact Us
Filters
Showing results (1-10 of 275) with videos related to
Page
of 28
Sort By:
Cancer
|
April 28, 2011
Treatment of cancer in adolescents and young adults: is affordability a concern?
Amiram Gafni
Health Economics, Policy, and Law
|
March 10, 2015
On the margins of health economics: a response to 'resolving NICE'S nasty dilemma'
Stephen Birch, Amiram Gafni
International Journal of Health Services : Planning, Administration, Evaluation
|
August 27, 2005
Achievements and challenges of medicare in Canada: Are we there yet? Are we on course?
Stephen Birch, Amiram Gafni
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy
|
August 17, 2006
Can I accurately predict the impact of an illness and its treatment on my future subjective well-being? A complex question that does not have a simple answer
Cathy Charles, Amiram Gafni
Journal of Comparative Effectiveness Research
|
March 21, 2014
The vexing problem of defining the meaning, role and measurement of values in treatment decision-making
Cathy Charles, Amiram Gafni
Journal of Clinical Epidemiology
|
November 14, 2022
Heterogeneity in multicentre trial participating centers: lessons from the TOPCAT trial on interpreting trial data for clinical practice
Mathew Mercuri, Amiram Gafni
Pharmacoeconomics
|
October 28, 2006
Information created to evade reality (ICER): things we should not look to for answers
Stephen Birch, Amiram Gafni
Social Science & Medicine (1982)
|
December 6, 2005
Incremental cost-effectiveness ratios (ICERs): the silence of the lambda
Amiram Gafni, Stephen Birch
Journal of Health Economics
|
December 17, 2009
The additive utility assumption of the QALY model revisited
Afschin Gandjour, Amiram Gafni
Health Economics, Policy, and Law
|
July 19, 2008
Economists' dream or nightmare? Maximizing health gains from available resources using the NICE guidelines
Stephen Birch, Amiram Gafni
Page
of 28
Search research articles
Search
Showing results (1-10 of 275) with videos related to
Sort By:
Page
of 28
Cancer
|
April 28, 2011
Treatment of cancer in adolescents and young adults: is affordability a concern?
Amiram Gafni
Health Economics, Policy, and Law
|
March 10, 2015
On the margins of health economics: a response to 'resolving NICE'S nasty dilemma'
Stephen Birch, Amiram Gafni
International Journal of Health Services : Planning, Administration, Evaluation
|
August 27, 2005
Achievements and challenges of medicare in Canada: Are we there yet? Are we on course?
Stephen Birch, Amiram Gafni
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy
|
August 17, 2006
Can I accurately predict the impact of an illness and its treatment on my future subjective well-being? A complex question that does not have a simple answer
Cathy Charles, Amiram Gafni
Journal of Comparative Effectiveness Research
|
March 21, 2014
The vexing problem of defining the meaning, role and measurement of values in treatment decision-making
Cathy Charles, Amiram Gafni
Journal of Clinical Epidemiology
|
November 14, 2022
Heterogeneity in multicentre trial participating centers: lessons from the TOPCAT trial on interpreting trial data for clinical practice
Mathew Mercuri, Amiram Gafni
Pharmacoeconomics
|
October 28, 2006
Information created to evade reality (ICER): things we should not look to for answers
Stephen Birch, Amiram Gafni
Social Science & Medicine (1982)
|
December 6, 2005
Incremental cost-effectiveness ratios (ICERs): the silence of the lambda
Amiram Gafni, Stephen Birch
Journal of Health Economics
|
December 17, 2009
The additive utility assumption of the QALY model revisited
Afschin Gandjour, Amiram Gafni
Health Economics, Policy, and Law
|
July 19, 2008
Economists' dream or nightmare? Maximizing health gains from available resources using the NICE guidelines
Stephen Birch, Amiram Gafni
Page
of 28